SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as investors prepare for an eagerly awaited earnings release, with the community closely tracking whether the companys pivot to profitability and new leadership will catalyze a potential breakout. While bullish sentiment is fueled by hope for a short squeeze and faith in the new executive team's vision, some participants remain cautious due to broader housing market headwinds and the volatility typically associated with the stock's earnings cycles.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The Roaring Kitty community is rallying behind the $ROAR token, fueled by persistent speculation regarding a potential $GME-related catalyst and the token's 100% community-driven, decentralized structure. Holders are actively discussing exchange listing rumors and the project's multi-chain presence as indicators of long-term upside potential.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors digest a stronger-than-expected earnings beat and an expanding roster of high-profile partnerships for its Matrix-M adjuvant technology. The community is actively debating the impact of these licensing agreements, the potential for an oncology-focused catalyst, and the ongoing activist campaign led by Shah Capital ahead of the upcoming board vote.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending due to optimistic preclinical data showing 100% tumor clearance in ovarian cancer models, which has sparked intense debate among traders regarding the company's long-term potential versus concerns over historical dilution and reverse splits. The community remains sharply divided between those positioning for a potential short squeeze on a low-float setup and skeptics warning that the data is limited to animal models.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing significant volatility and high trading volume as investors react to strong earnings and a strategic shift toward ruggedized edge computing for defense and AI applications. Community discussion is focused on the company's long-term potential within the defense-tech and AI infrastructure sectors, with many market participants viewing recent price swings as accumulation opportunities despite ongoing short-term volatility.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending following a massive strategic partnership with NVIDIA, which includes a landmark manufacturing expansion to supply critical optical infrastructure for the booming AI data center market. Investors are closely monitoring the stock as it scales fiber production capacity to meet hyperscale demand, with the community actively debating whether this represents a long-term re-pricing of the company as an essential AI backbone or an overextended growth narrative.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing significant attention as community members debate its potential as a long-term AI-driven utility play following recent exchange listings and expanded integration within the Base ecosystem. Investors are actively discussing the coin's technical patterns and market cap potential, balancing enthusiasm for its autonomous agent features against concerns over price volatility and broader macro-economic pressures.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is trending as investors weigh significant balance sheet improvements, including debt reduction and recent tax refunds, against ongoing concerns about negative margins and operational execution. Community discussion is heavily divided between those viewing the current valuation as an asymmetric long-term opportunity and those remaining skeptical due to the company's past bankruptcy and high short interest.

Tidal Trust III - MRP SynthEquity ETF

MRP SynthEquity ETF

Investors are gravitating toward SNTH as a strategic alternative to traditional index funds, focusing on its ability to capture market upside while potentially mitigating drawdown risks. The community is actively debating the fund's unique risk-management structure and its performance relative to standard S&P 500 trackers.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is trending as investors react to a multi-billion dollar data center contract with AI chip maker Cerebras, fueling bullish sentiment despite concerns regarding dilution from their ATM offering. The community is actively discussing a potential squeeze driven by high short interest and anticipation surrounding the upcoming Cerebras IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The deal is expected to advance its cancer immunotherapy candidate VXM01, which has shown promising results in early studies for glioblastoma and pancreatic cancer.</li><li>Under the agreement, BCME will get exclusive rights to develop, manufacture, and commercialize the drug.</li><li>BCME has pledged its nearly 30% stake in the OSRH as collateral to back the milestone payments.</li></ul>Shares of OSR Holdings Inc. (OSRH) soared 60% on Thursday, marking their biggest one-day jump in over eight months, as investors welcomed a newly finalized global licensing deal that could bring in up to $815 million in milestone payments.OSR Holdings signed an agreement with BCM Europe (BCME) to advance its cancer immunotherapy candidate VXM01, an oral treatment targeting VEGFR-2, a protein found on blood vessels that helps control how blood cells grow and survive.VXM01 has shown promising results in early studies for aggressive cancers such as glioblastoma and pancreatic cancer.<h2 class="st-heading-2">$815M Licensing Deal</h2>Under the agreement, BCME will get exclusive rights to develop, manufacture, and commercialize the drug, while OSR could receive up to $815 million in milestone payments tied to clinical, regulatory, and commercial progress.BCME, OSR’s largest shareholder, has pledged its nearly 30% stake in the company as collateral to back the milestone payments. OSR will also earn full royalties after BCME recovers its investment.“This agreement establishes a clear, accountable framework for the development of VXM01. It ensures OSR Holdings shareholders participate directly in value creation, while BCME remains accountable for its financial commitments,” said Peter Hwang, CEO of OSR Holdings.<h2 class="st-heading-2">Retail Bulls Expect Stock To Hit The $1 Mark</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/OSRH">OSRH</a> on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, amid ‘extremely high’ message volumes.Users expect the stock to climb to $1, following the latest update. The stock last traded at that level on Aug. 26, 2025.<stembedurl>https://stocktwits.com/Stellarspider/message/651893470</stembedurl><stembedurl>https://stocktwits.com/sadalmas/message/651891224</stembedurl>Over 193 million shares changed hands on Thursday, compared to the daily average of roughly 1.1 million, according to Stocktwits data.The company first received a Nasdaq notice in September for failing to meet the $1 minimum share price requirement and was initially given until March 4, 2026, to regain compliance. It has now been granted an additional 180 days, giving it until Aug. 31, 2026, to meet the requirement.The stock has gained 15% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

OSRH Stock Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock

The company signed a global licensing deal with BCM Europe that could bring in up to $815 million in milestone payments.

OSRH Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock

Equity

OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?

OSR Holdings shares surged 41.28% after securing a global exclusive licensing deal for its Phase 3-ready cancer immunotherapy VXM01, with potential milestone payments up to $815 million.read more...

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR...

<ul class="summary-bullets"><li>OSR Holdings has until Aug. 31, 2026, to maintain a closing share price of at least $1 for ten consecutive business days.</li><li>Unit Vaximm immuno-oncology asset is pursuing a global licensing deal immuno-oncology asset that could include a $30 million upfront payment and $815 million in milestones.</li><li>OSR said that it is progressing with the planned merger of its units, RMC and Woori IO.</li></ul>Shares of OSR Holdings, Inc. (OSRH) surged more than 20% on Thursday after the company announced that it received an additional 180-day extension from Nasdaq to regain compliance with the exchange’s minimum bid price requirement.On a closing basis, <a href="https://stocktwits.com/symbol/OSRH">OSRH stock</a> is on track to record its biggest intra-day gains so far this year.Nasdaq initially notified OSR Holdings on Sept. 9, 2025, that it was not in compliance with the exchange’s $1 minimum bid price rule after its shares had traded below that level from August 25. OSR was given till March 4, 2026, to regain compliance.The company now has until Aug. 31, 2026, to meet the rule by maintaining a closing share price of at least $1 for ten consecutive business days. OSR noted that there is no immediate impact on the listing or trading of its stock.“We view this extension as a clear operational runway for our strategic initiatives to mature and translate into tangible shareholder value. With multiple near-term catalysts advancing, we believe OSR Holdings is well positioned to strengthen its capital markets profile and return to compliance through disciplined execution,” said Tim Smith, Head of Investor Relations.<h2 class="st-heading-2">Vaximm’s Potential Global Licensing Deal Could Fetch $815 Million</h2>Meanwhile, the company said it remains focused on several strategic initiatives. Its unit Vaximm is working toward a potential global licensing deal for its immuno-oncology asset VXM01, which could include $30 million upfront and up to $815 million in milestone payments.OSR is also progressing with the planned merger of its units, RMC and Woori IO, to build an integrated medical technology and distribution platform, while exploring global partnerships for Woori IO’s non-invasive glucose monitoring technology.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high message volumes.One user expects the stock to reach $10 in the short term.<stembedurl>https://stocktwits.com/JJBurch/message/646695066</stembedurl>The stock has shed around 15% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did OSRH Stock Jump 20% Today?

The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical...

Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to...

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones Vaximm, an OSR Company, Receives Binding Term...

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings PR...

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period...

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 PR Newswire BELLEVUE, Wash., Dec. 1, 2025...

OSR Holdings, Inc. operates as a global healthcare company. The firm engages in developing oral immunotherapies for cancer treatment, design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention of medical devices and systems distribution in Korea. Its products are offered through its subsidiaries. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.

OSR Holdings Inc.

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

OSRH
OSR Holdings Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest OSRH News

OSRHOSR Holdings Inc